Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.

Systemic markers of inflammation and cognitive decline in old age.

Schram MT, Euser SM, de Craen AJ, Witteman JC, Frölich M, Hofman A, Jolles J, Breteler MM, Westendorp RG.

J Am Geriatr Soc. 2007 May;55(5):708-16.

PMID:
17493190
2.

Serum inflammatory proteins and cognitive decline in older persons.

Dik MG, Jonker C, Hack CE, Smit JH, Comijs HC, Eikelenboom P.

Neurology. 2005 Apr 26;64(8):1371-7.

PMID:
15851726
3.

Serum calcium and cognitive function in old age.

Schram MT, Trompet S, Kamper AM, de Craen AJ, Hofman A, Euser SM, Breteler MM, Westendorp RG.

J Am Geriatr Soc. 2007 Nov;55(11):1786-92.

PMID:
17979900
4.

APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.

van Vliet P, Oleksik AM, Mooijaart SP, de Craen AJ, Westendorp RG.

Neurology. 2009 Mar 3;72(9):821-8. doi: 10.1212/01.wnl.0000343852.10018.24.

PMID:
19255409
5.

Inflammatory markers and cognition in well-functioning African-American and white elders.

Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, Launer L, Kuller L, Rubin S, Harris T.

Neurology. 2003 Jul 8;61(1):76-80.

PMID:
12847160
6.

Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study.

Rafnsson SB, Deary IJ, Smith FB, Whiteman MC, Rumley A, Lowe GD, Fowkes FG.

J Am Geriatr Soc. 2007 May;55(5):700-7.

PMID:
17493189
7.

Inflammatory markers and loss of muscle mass (sarcopenia) and strength.

Schaap LA, Pluijm SM, Deeg DJ, Visser M.

Am J Med. 2006 Jun;119(6):526.e9-17.

PMID:
16750969
8.

Serum high sensitivity C-reactive protein and cognitive function in elderly women.

Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Penttilä IM, Helkala EL, Gylling H, Nissinen A, Rauramaa R.

Age Ageing. 2007 Jul;36(4):443-8. Epub 2007 May 30.

PMID:
17537742
9.

Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.

Knopman DS, Mosley TH, Catellier DJ, Coker LH; Atherosclerosis Risk in Communities Study Brain MRI Study..

Alzheimers Dement. 2009 May;5(3):207-14. doi: 10.1016/j.jalz.2009.01.027. Epub 2009 Apr 11.

PMID:
19362884
10.

Homocysteine and inflammation: predictors of cognitive decline in older persons?

van den Kommer TN, Dik MG, Comijs HC, Jonker C, Deeg DJ.

Neurobiol Aging. 2010 Oct;31(10):1700-9. doi: 10.1016/j.neurobiolaging.2008.09.009. Epub 2008 Nov 11.

PMID:
19004529
11.
12.

The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging.

Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE; MacArthur Studies of Successful Aging..

Neurology. 2003 Apr 8;60(7):1077-81.

PMID:
12682309
13.

Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.

Arch Neurol. 2007 Sep;64(9):1306-11.

PMID:
17846270
14.

Association between apolipoprotein E4 and cognitive decline in elderly adults.

Packard CJ, Westendorp RG, Stott DJ, Caslake MJ, Murray HM, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Jolles J, Perry IJ, Sweeney BJ, Twomey C; Prospective Study of Pravastatin in the Elderly at Risk Group..

J Am Geriatr Soc. 2007 Nov;55(11):1777-85.

PMID:
17979899
15.

Albumin, apolipoprotein E-epsilon4 and cognitive decline in community-dwelling Chinese older adults.

Ng TP, Niti M, Feng L, Kua EH, Yap KB.

J Am Geriatr Soc. 2009 Jan;57(1):101-6. doi: 10.1111/j.1532-5415.2008.02086.x. Epub 2008 Nov 19.

PMID:
19054180
16.

Plasma levels of apolipoprotein E and cognitive function in old age.

Mooijaart SP, van Vliet P, van Heemst D, Rensen PC, Berbée JF, Jolles J, de Craen AJ, Westendorp RG.

Ann N Y Acad Sci. 2007 Apr;1100:148-61.

PMID:
17460173
17.

Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.

Stonnington CM, Snyder PJ, Hentz JG, Reiman EM, Caselli RJ.

J Clin Psychiatry. 2009 Oct;70(10):1379-84. doi: 10.4088/JCP.08m04593. Epub 2009 Jun 30.

PMID:
19573495
18.

Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study.

Mooijaart SP, Sattar N, Trompet S, Lucke J, Stott DJ, Ford I, Jukema JW, Westendorp RG, de Craen AJ; PROSPER Study Group..

J Intern Med. 2013 Jul;274(1):77-85. doi: 10.1111/joim.12052. Epub 2013 Mar 11.

19.

Measuring cognitive function with age: the influence of selection by health and survival.

Euser SM, Schram MT, Hofman A, Westendorp RG, Breteler MM.

Epidemiology. 2008 May;19(3):440-7. doi: 10.1097/EDE.0b013e31816a1d31.

PMID:
18414086
20.

Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging.

Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE.

Neurology. 2002 Aug 13;59(3):371-8.

PMID:
12177370

Supplemental Content

Support Center